Incidence
Non-specific inflammatory bowel diseases are those for which there is no discernible aetiological agent. The two most important of these diseases affecting the large bowel are ulcerative colitis and Crohn's disease. Ulcerative colitis is always confined to the large bowel, although a few centimetres of the terminal ileum may be affected by "backwash" ileitis. On the other hand, Crohn's disease affects the whole of the gastrointestinal tract, although the only manifestation may be in the large bowel.
The incidence of ulcerative colitis has remained static at 26/100 000 population. The incidence of Crohn's disease rose from an annual incidence of 0-7/100 000 to 5/100 000 in the past three decades. Women are more commonly affected by Crohn's disease than men and both sexes have a peak onset in their 20s-40s with a secondary peak in their 70s. Ulcerative colitis has a similar age distribution but the sex incidence is equal.
Pathology
Histological slides showing ulcerative colitis (far left) confined to the mucosa and small bowel in Crohn's disease (left) with transmural inflammation and a fissuring ulcer.
Ulcerative colitis usually begins distally as proctitis and then spreads proximally to affect the whole ofthe large bowel. In some cases, however, it remains confined to the rectum. Crohn's disease typically affects segments of the gastrointestinal tract with areas of diseased bowel separated by intervening areas ofmacroscopically normal bowel. The most common area to be affected is the terminal ileum and caecum (ileocolitis). The next most common area is the colon (Crohn's colitis). Isolated jejunal and ileal Crohn's disease also occurs.
The essential difference between ulcerative colitis and Crohn's disease is the extent of the inflammation. The inflammation of ulcerative colitis is confined to the mucosa, whereas in Crohn's disease it is transmural and is associated with fissuring ulcers and granulomas. Extraintestinal manifestations of inflammatory bowel disease occur in both ulcerative colitis and Crohn's disease. These include eye disorders, for example, episcleritis and iridocyclitis; joint disorders -for example, arthralgia, arthritis, and sacroiliitis; skin lesions -for example, erythema nodosum and pyoderma gangrenosum; aphthous mouth ulcers; finger clubbing; and sclerosing cholangitis. Ankylosing spondylitis is much commoner in patients with ulcerative colitis and Crohn's disease (1 in 100) than in the general population (1 in 10 000).
Sigmoidoscopy is the most useful initial investigation in a patient presenting with diarrhoea and rectal bleeding. Other common causes of these symptoms are colorectal cancer and specific inflammatory bowel disease (infective diarrhoeas, pseudomembranous colitis, radiation enteritis, and ischaemic colitis). Sigmoidoscopy will distinguish proctocolitis from other conditions. In mild distal proctocolitis there is diffuse hyperaemia of the rectal mucosa. With more active disease there is granularity of the mucosa and contact bleeding. With severe proctocolitis a purulent exudate is seen coating the mucosa and blood oozes from its surface.
Biopsy specimens should be taken as if granulomas are present Crohn's colitis can be diagnosed. A stool sample should be sent for culture to exclude infective dysenteries. Campylobacter often produces a bloody diarrhoea and this can also occur with salmonella and shigella. Pseudomembranous colitis occurs in patients who have recently-received treatment with broad spectrum antibiotics-it is caused by overgrowth of Clostridium difficile. A patchy fibrinous membrane coating the mucosa is seen on sigmoidoscopy. C difficile and its toxin should be looked for on stool culture.
Barium enema examination is useful in distinguishing Crohn's colitis from ulcerative colitis and in assessing the extent and severity of colitis. Crohn's colitis is characterised by a discontinuous distribution, often with rectal sparing. Diseased segments have a cobblestoned appearance caused by deep longitudinal and transverse ulcers. "Rosethorn" ulcers may be present, which sometimes perforate to produce fistulous tracks. Mild ulcerative colitis is characterised by a disturbed mucosal pattern with small ulcers. Pseudopolyps may form in patients with more severe disease. With longstanding severe disease there is a loss of haustral markings with a featureless, shortened hosepipe colon.
Colonoscopy is also useful in assessing colitis. Although it is a more time consuming examination, biopsy specimens can be taken for histological examination. This is particularly important in the surveillance of patients with long standing and widespread ulcerative colitis as it allows severe dysplasia and early invasive cancer to be detected.
The most useful investigation in patients with suspected small bowel or ileocaecal Crohn's disease is small bowel enema examination. Small bowel Crohn's disease is characterised by the radiological "string sign," which is caused by extreme narrowing of the intestinal lumen. Fistulous tracks may also be seen.
Useful blood measurements for assessing the severity of inflammatory bowel disease and assessing the response to treatment are serum albumin concentration, which is low in patients with active disease, and erythrocyte sedimentation rate and orosomucoid and C reactive protein concentrations, which are raised in patients with active disease. Sulphasalazine is of proved value in suppressing disease activity and maintaining remission in both patients with ulcerative colitis and those with Crohn's colitis. It should be given while patients have symptoms but may be stopped after several years of complete remission. A dose of 2-4 g a day is required to be effective. This can produce side effects such as nausea, vomiting, and skin rashes; slow release mesalazine is an effective alternative.
Local topical steroid preparations (such as Colifoam and Predsol enemas) are used for exacerbations of distal proctocolitis. They can be gradually tailed off as symptoms and sigmoidoscopic appearance improve. Oral prednisolone is required to control exacerbations of more widespread colitis. The dose can usually be reduced as the patients' symptoms improve. Occasionally, reduction of dosage is not possible without provoking an exacerbation of colitis, resulting in the need for long term high dosages of steroids. In these patients azathioprine can be added as an additional immunosuppressant, allowing the steroid dose to be reduced and thus reducing the risk of side effects such as osteoporosis. Azathioprine can produce marrow suppression and the blood count will need to be monitored regularly.
Patients with severe attacks of widespread colitis may have constitutional disturbances including fever, tachycardia, weight loss, and anaemia. Hospital admission is required and treatment comprises bed rest, intravenous fluids, fasting, and intravenous hydrocortisone. Patients must be carefully monitored as toxic dilatation can develop.
Indications for elective colectomy in ulcerative colitis are to restore health in patients with chronic disease, to eliminate the risk of side effects of steroids in patients requiring long term high dosages of steroids, premalignant change on colonoscopic surveillance, and patients at high risk of developing cancer (those with early onset of disease, extensive colonic involvement, and continuous rather than episodic symptoms). Panproctocolectomy is the procedure of choice in middle aged and elderly patients. An intersphincteric approach must be used when removing the rectum to avoid damage to the pelvic autonomic nerves. Younger patients should be given the option of a sphincter preserving operation in which a pouch is constructed from a duplicated or triplicated loop of ileum.
The rectum is excised, leaving behind the anal canal with its intact sphincter mechanism. The pouch is then anastomosed to the dentate line. This gives excellent results in most cases, with complete continence and spontaneous evacuation occurring 4-6 times a day. 
